Company: BIAF
Filing Date: 2025-04-22
Form Type: 424B3
Source: 0001641172-25-005598
Chunk: 69

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-22
Form: 424B3
Chunk 69
---
 the Warrants. Upon exercise of the warrants, the holders will be titled to exercise the rights of a stockholder only
as to matters for which the record date occurs after the date they were entered in the register of members of the Company as a stockholder.

The warrant certificates governing our warrants designate the state and federal courts of the State of New York sitting in the City of New York, Borough of Manhattan, as the exclusive forum for actions and proceedings with respect to all matters arising out of the warrants, which could limit a warrant holder’s ability to choose the judicial forum for disputes arising out of the warrants.

The warrant certificates governing our warrants provide
that all legal proceedings concerning the interpretations, enforcement, and defense of the transactions contemplated by the warrant certificate
(whether brought against a party to the warrant certificate or their respective affiliates, directors, officers, shareholders, partners,
members, employees, or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. The warrant
certificates further provide that we and the warrant holders irrevocably submit to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, Borough of Manhattan, for the adjudication of any dispute under the warrant certificate or in
connection with it or with any transaction contemplated by it or discussed in it. Furthermore, we and the warrant holders irrevocably
waive, and agree not to assert in any suit, action, or proceeding, any claim that we or they are not personally subject to the jurisdiction
of any such court, that such suit, action, or proceeding is improper or is an inconvenient venue for such proceeding. With respect to
any complaint asserting a cause of action arising under the Securities Act or the rules and regulations promulgated thereunder, we note,
however, that there is uncertainty as to whether a court would enforce this provision and that investors cannot waive compliance with
the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction
for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations
thereunder. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability
created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision in the warrant certificates
expressly does not apply to suits brought to enforce any duty or liability created by the Exchange Act.

Any